This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Malignant neoplasm of other and unspecified major salivary glands, excluding all cancers (controls excluding all cancers)
C3_SALIVARYNAS_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
265 |
4. Check minimum number of eventsNone |
265 |
5. Include endpointsNone |
265 |
6. Filter based on genotype QC (FinnGen only) |
265 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of other and unspecified major salivary glands, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
- Neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 265 | 124 | 141 |
| Unadjusted period prevalence (%) | 0.05 | 0.04 | 0.06 |
| Median age at first event (years) | 61.79 | 57.64 | 65.45 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 101
- Matched controls
- 1011
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
ELB30
NOMESCO Finland
Excision of submandibular gland
691.1
44.9
41
*
C08.09
ICD-10 Finland
Malignant tumor of the submandibular or submaxillary gland, other or unspecified histology
+∞
34.3
31
*
130
Kela drug reimbursment
Malignant tumour
+∞
33.1
30
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
33.1
30
*
D11.70
ICD-10 Finland
Gland sublingual
+∞
33.1
30
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
10.9
26.5
69
166
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
+∞
25.0
23
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
32.7
24.5
32
14
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
21.6
20
*
C08.02
ICD-10 Finland
Cystic adenocarcinoma of the submandibular or submaxillary glands
+∞
21.6
20
*
XX3DW
NOMESCO Finland
Time consuming IT work
17.5
20.5
33
27
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
19.7
19.7
30
21
8200/3-C08.0
ICD-O-3
Adenoid cystic carcinoma of submandibular gland
+∞
19.4
18
*
H02AB02
ATC
dexamethasone; systemic
201.8
17.0
17
*
C08.00
ICD-10 Finland
Malignant tumor of submandibular or submaxillary gland, not histology
+∞
16.0
15
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
32.9
14.9
19
7
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
62.6
14.3
16
*
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
40.3
14.0
17
5
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
13.9
13
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
13.9
13
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
13.9
13
*
A04AA02
ATC
granisetron; systemic, transdermal
160.6
13.8
14
*
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
23.9
13.0
18
9
WF002
NOMESCO Finland
Radical radiotherapy
+∞
12.8
12
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
12.8
12
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
12.8
12
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
12.8
12
*
Z51.5
ICD-10 Finland
Palliative care
19.1
12.7
19
12
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
73.7
11.9
13
*
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
134.6
11.7
12
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
11.7
11
*
D37.00
ICD-10 Finland
Aryepiglottic fold marginal zone
40.1
11.6
14
*
C08.90
ICD-10 Finland
Malignant tumor in unspecified large salivary gland without histology
+∞
10.6
10
*
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
+∞
10.6
10
*
N02AA05
ATC
oxycodone; systemic
5.8
10.5
32
74
A07AA02
ATC
nystatin; oral
10.9
10.1
19
21
SAA03
NOMESCO Finland
Extended examination of mouth
4.0
9.9
57
247
A03FA01
ATC
metoclopramide; systemic, rectal
6.6
9.8
26
50
C08.01
ICD-10 Finland
Diverse adenocarcinoma of the mandibular salivary gland
+∞
9.5
9
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
9.5
9
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
9.5
9
*
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
+∞
9.5
9
*
C08.0
ICD-10 Finland
Malignant neoplasm: Submandibular gland
+∞
9.5
9
*
WX408
NOMESCO Finland
General anesthesy, balanced
4.4
9.2
38
121
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
26.9
9.1
12
5
XW000
NOMESCO Finland
Bone marrow biopsy
16.3
8.5
13
9
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
3.5
8.4
57
270
9699/3-C08.0
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of submandibular gland
+∞
8.4
8
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
8.4
8
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
8.4
8
*
JN4BD
NOMESCO Finland
Extensive body CT
9.0
8.3
17
22
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
9.8
8.2
16
19
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
5.6
8.1
24
53
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
48.9
7.8
9
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
48.9
7.8
9
*
C08.94
ICD-10 Finland
Mucoepidermoid carcinoma of an unspecified large salivary gland
+∞
7.4
7
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
+∞
7.4
7
*
8200/3-C08.9
ICD-O-3
Adenoid cystic carcinoma of major salivary gland, NOS
+∞
7.4
7
*
8430/3-C08.0
ICD-O-3
Mucoepidermoid carcinoma of submandibular gland
+∞
7.4
7
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
7.4
7
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
7.4
7
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
7.4
7
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
+∞
7.4
7
*
L02BB03
ATC
bicalutamide; oral
+∞
7.4
7
*
WZC30
NOMESCO Finland
Teaching
4.7
6.5
22
56
L03AA02
ATC
filgrastim; parenteral
74.3
6.5
7
*
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
74.3
6.5
7
*
JN6AD
NOMESCO Finland
CT of torso and neck
28.6
6.3
8
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
28.6
6.3
8
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
6.3
6
*
EJB30
NOMESCO Finland
Excision of lesion of floor of mouth
+∞
6.3
6
*
C08.91
ICD-10 Finland
Adenocarcinoma of mixed cell type in unspecified large salivary gland
+∞
6.3
6
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
6.3
6
*
C08.9
ICD-10 Finland
Malignant neoplasm: Major salivary gland, unspecified
+∞
6.3
6
*
EHB00
NOMESCO Finland
Excision of lesion of palate
+∞
6.3
6
*
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
+∞
6.3
6
*
A04AD12
ATC
aprepitant; systemic
+∞
6.3
6
*
B01AB10
ATC
tinzaparin; parenteral
8.9
6.0
12
15
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
16.3
6.0
9
6
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
86
52
24.00
107.82
1.6
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
65
22
38.82
101.12
1.4
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
56
146
4.60
20.35
1.4
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
125
606
3.01
17.20
3.3
1.6
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
139
837
2.39
10.97
4.2
3.4
g/l
34.8
35.8
1.40
128
772
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
136
816
2.37
10.76
4.0
3.6
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
161
1053
2.35
10.25
12.3
6.4
e9/l
4.2
4.2
0.20
150
916
(3015377) Calcium [Moles/volume] in Serum or Plasma
110
627
2.29
9.53
4.2
2.0
mmol/l
2.4
2.3
0.05
97
516
(3023368) Bacteria identified in Blood by Culture
92
497
2.30
8.95
5.1
3.7
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
12
16
7.81
8.48
1.3
1.9
mosm/kgh2o
294.1
275.4
1.62
12
11
(40760892) CBC W Ordered Manual Differential panel - Blood
77
402
2.29
8.00
4.7
4.7
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
52
227
2.61
7.98
2.3
1.7
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
145
981
2.06
7.61
8.9
3.7
umol/l
10.2
11.8
2.17
139
915
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
139
952
1.97
6.78
6.6
5.4
mmol/l
1.2
1.2
0.23
107
811
(3022096) Basophils/100 leukocytes in Blood
128
854
1.96
6.73
5.2
5.2
%
0.6
0.7
0.59
120
780
(3042111) Morphology [Interpretation] in Bone marrow Narrative
13
25
5.42
6.56
1.1
2.3
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
142
992
1.93
6.41
5.5
5.2
e9/l
0.2
0.2
1.66
128
861
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
20
57
3.71
6.29
2.1
2.5
mg/l
1.1
1.6
3.42
20
51
(3003694) ABO and Rh group [Type] in Blood
80
462
2.05
6.25
1.4
1.3
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
10
8
12.93
6.13
3.2
1.6
ug/l
14.6
12.8
—
10
8
(3032080) INR in Blood by Coagulation assay
121
812
1.90
6.08
9.4
9.1
inr
1.3
1.3
0.39
46
226
(3001604) Monocytes [#/volume] in Blood
136
949
1.89
6.05
5.3
5.0
e9/l
0.5
0.6
1.19
124
802
(3044640) Blood type and Crossmatch panel - Blood
89
541
1.97
5.99
2.4
2.0
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
127
871
1.88
5.92
5.6
4.9
mmol/l
1.2
1.2
1.11
109
765
(3006504) Eosinophils/100 leukocytes in Blood
128
881
1.88
5.90
5.1
5.2
%
2.8
3.1
0.65
120
803
(3002030) Lymphocytes/100 leukocytes in Blood
130
902
1.87
5.82
5.2
5.3
%
24.8
27.8
1.70
120
822
(3019069) Monocytes/100 leukocytes in Blood
128
886
1.86
5.75
5.3
5.5
%
8.7
8.7
0.07
120
812
(3019198) Lymphocytes [#/volume] in Blood
137
970
1.85
5.72
5.4
5.1
e9/l
1.7
1.8
0.51
126
839
(3018010) Neutrophils/100 leukocytes in Blood
128
895
1.83
5.49
4.7
5.2
%
59.9
57.0
1.50
120
822
(3006315) Basophils [#/volume] in Blood
135
960
1.83
5.48
5.5
5.0
e9/l
0.0
0.0
2.52
124
816
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
188
1490
1.90
5.28
10.2
5.3
u/l
80.3
75.3
0.75
174
1360
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
5
0
+∞
5.22
1.0
0.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
41
195
2.30
5.16
4.1
3.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
71
418
1.95
5.15
2.1
2.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
8
7
11.73
4.81
5.8
2.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
28
118
2.54
4.58
3.9
5.3
%
0.0
0.1
—
8
19
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
33
153
2.32
4.40
3.0
2.0
ml/min/173m2
70.1
61.1
0.60
11
58
(3003458) Phosphate [Moles/volume] in Serum or Plasma
47
252
2.05
4.39
4.9
4.9
mmol/l
1.0
1.0
0.93
42
221
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
10
22
4.68
4.34
1.2
1.2
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
155
1207
1.68
4.13
5.2
4.0
mmol/l
6.9
6.7
0.50
146
1112
(3017181) Myelocytes/100 leukocytes in Blood
29
131
2.36
4.10
3.8
5.1
%
0.9
0.8
—
8
29
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
26
113
2.44
4.00
1.3
1.3
—
—
—
0
0
(3018418) pH of Serum or Plasma
83
555
1.72
3.87
3.7
3.3
ph
7.4
7.4
0.31
21
89
(3042936) Bacteria identified in Isolate by Culture
50
288
1.91
3.80
2.1
1.8
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
7
8
8.95
3.79
1.6
1.0
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
27
124
2.31
3.69
4.0
5.2
%
0.0
0.1
—
8
24
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
6
6
10.19
3.51
1.2
1.0
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
7
10
7.15
3.38
5.6
1.9
nmol/l
2.1
5.0
—
7
10
(42870588) Differential panel, method unspecified - Blood
88
629
1.60
3.08
4.8
5.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
13
45
2.99
3.07
1.2
1.5
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
8
7.64
3.07
2.2
2.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
49
302
1.76
2.99
2.1
1.7
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
11
35
3.24
2.96
1.4
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
45
272
1.79
2.93
9.1
7.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
9
22
4.20
2.91
1.0
1.0
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
15
59
2.63
2.84
3.3
2.9
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
24
118
2.14
2.82
4.3
5.3
%
0.7
0.4
—
7
20
(3045142) Bone marrow Pathology biopsy report
7
14
5.10
2.74
1.3
1.1
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
67
460
1.61
2.73
3.8
3.2
%
87.7
88.6
0.12
67
446
(3003396) Base excess in Arterial blood by calculation
36
210
1.83
2.63
6.5
6.0
mmol/l
1.6
1.6
0.00
28
163
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
36
211
1.82
2.59
6.4
5.9
kpa
5.5
5.2
0.88
29
202
(3027801) Oxygen [Partial pressure] in Arterial blood
36
211
1.82
2.59
6.4
5.9
kpa
15.6
11.5
2.17
29
203
(3003434) Protein [Mass/volume] in Pleural fluid
8
20
4.09
2.59
1.3
1.1
g/l
33.3
24.1
—
8
15
(21494890) Protein electrophoresis panel - 24 hour Urine
8
20
4.09
2.59
1.3
1.1
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
108
837
1.49
2.53
12.3
8.2
e9/l
0.0
0.0
0.60
92
681
(3012441) Differential panel - Pleural fluid
7
16
4.46
2.49
1.0
1.0
—
—
—
0
0
(3019225) pH of Specimen
34
199
1.81
2.46
4.4
3.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
10
34
3.02
2.44
1.1
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
18
350
0.48
2.43
1.2
1.3
u/ml
57.0
12.7
—
7
130
(40768806) Pleura Pathology biopsy report
6
12
5.09
2.41
1.8
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
20
368
0.51
2.29
1.2
1.3
iu/ml
131.6
38.4
—
8
114
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
35
212
1.75
2.27
1.7
1.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
25
137
1.91
2.22
1.6
1.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
63
450
1.52
2.14
9.3
4.8
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
10
37
2.77
2.13
1.1
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
8
25
3.27
2.11
1.1
1.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
22
118
1.94
2.09
1.5
1.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
34
211
1.70
2.04
2.0
1.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
77
582
1.46
1.97
3.3
3.0
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
9
33
2.79
1.95
1.6
1.3
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
11
4.61
1.95
2.2
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
0
51
0.00
1.91
0.0
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
0
51
0.00
1.91
0.0
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
0
51
0.00
1.91
0.0
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
0
50
0.00
1.91
0.0
1.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
58
417
1.50
1.90
2.3
2.4
e6/l
4.5
5.7
0.41
52
353
(3027944) Amphetamines [Presence] in Urine
0
52
0.00
1.90
0.0
1.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
172
1504
1.41
1.90
4.2
4.3
mm/h
12.8
11.7
0.57
154
1363
(3042631) Mycobacterium sp identified in Specimen
7
22
3.24
1.89
3.0
2.9
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
13
59
2.27
1.87
2.0
1.4
mg/l
20.9
28.7
1.48
13
49
(3034860) Kappa light chains.free [Mass/volume] in Serum
13
59
2.27
1.87
2.0
1.4
mg/l
26.6
41.7
1.64
13
49
(40760888) Immunoglobulin light chains.free panel - Serum
10
40
2.56
1.86
2.0
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
7
23
3.10
1.81
1.1
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
29
2.81
1.80
1.1
1.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
9
36
2.55
1.75
4.7
2.1
e9/l
3.8
4.6
—
9
36
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
219
2017
1.49
1.69
21.5
12.4
mg/l
29.9
22.9
1.97
185
1545
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
7
25
2.85
1.66
1.1
1.2
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
229
2133
1.54
1.63
22.8
15.1
mmol/l
139.2
139.9
2.90
220
2060
(3045788) Cell count panel - Pleural fluid
5
14
3.62
1.62
1.2
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
7
158
0.43
1.61
1.7
1.8
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
7
26
2.74
1.59
1.7
2.7
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
11
51
2.21
1.52
4.4
3.6
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
11
51
2.21
1.52
1.9
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
14
72
2.00
1.52
1.7
1.6
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
229
2142
1.51
1.49
22.7
15.2
mmol/l
4.0
4.0
0.40
221
2070
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
9
37
2.48
1.49
4.6
2.7
%
56.3
58.6
—
9
37
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
9
38
2.42
1.47
1.3
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
9
38
2.42
1.47
1.3
1.2
—
—
—
0
0
(44790049)
5
16
3.16
1.44
1.0
1.1
—
—
—
0
0
(44806118)
5
16
3.16
1.44
1.0
1.1
—
—
—
0
0
(44790047)
5
16
3.16
1.44
1.0
1.1
—
—
—
0
0
(44790048)
5
16
3.16
1.44
1.0
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
42
565
0.70
1.35
1.4
1.7
mmol/l
1.5
1.3
0.75
31
470
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
39
0.00
1.35
0.0
1.3
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
86
704
1.33
1.32
3.3
3.0
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
24
2.53
1.31
1.2
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
5
18
2.81
1.29
1.2
1.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
5
18
2.81
1.29
1.0
1.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
5
18
2.81
1.29
1.0
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
5
18
2.81
1.29
1.0
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
8
36
2.26
1.25
1.4
2.8
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
9
45
2.03
1.24
1.6
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
14
78
1.84
1.23
2.4
2.0
—
—
—
0
0
(4062490)
5
19
2.66
1.22
1.2
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
19
2.66
1.22
1.2
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
8
38
2.14
1.19
1.3
1.2
—
—
—
0
0
(3020891) Body temperature
15
87
1.77
1.17
4.3
4.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
5
111
0.44
1.16
1.6
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
20
2.53
1.15
1.2
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
20
2.53
1.15
1.2
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
20
2.53
1.15
1.2
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
20
2.53
1.15
1.2
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
20
2.53
1.15
1.2
1.1
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
20
127
1.62
1.15
4.4
1.7
g/l
8.8
10.6
1.35
20
116
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
64
785
0.76
1.14
4.6
3.9
ug/l
2.0
2.0
0.12
52
680
(3044889) 12 lead EKG panel
161
1453
1.28
1.13
3.7
4.0
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
17
104
1.68
1.12
2.7
1.2
g/l
0.8
1.1
1.70
17
94
(1761868) Lipid panel - Serum or Plasma
56
697
0.75
1.11
2.6
3.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
76
628
1.29
1.08
2.3
2.1
u/l
49.1
58.1
2.02
70
579
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
94
801
1.27
1.05
2.4
2.3
nmol/l
80.7
77.7
0.52
86
702
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
22
2.30
1.04
1.2
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
19
123
1.59
1.03
4.3
3.9
—
—
—
0
0
(3026782) Osmolality of Urine
49
383
1.34
1.03
2.6
2.6
mosm/kgh2o
515.9
540.9
0.32
42
305
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
30
407
0.70
1.02
1.2
1.2
u/ml
0.5
1.8
—
10
104
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
82
692
1.27
0.98
2.7
3.1
ng/l
1007.1
1262.2
0.52
72
576
(36660697) Celiac disease serology panel - Serum
8
145
0.54
0.96
1.0
1.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
23
159
1.49
0.95
7.7
6.9
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
165
1511
1.24
0.94
4.0
3.8
pmol/l
14.9
14.9
0.02
140
1350
(3044927) Protein electrophoresis panel - Urine
6
27
2.25
0.94
1.0
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
6
28
2.17
0.92
1.8
1.8
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
11
63
1.78
0.91
1.6
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
7
127
0.54
0.91
1.3
1.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
17
111
1.57
0.90
2.1
1.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
63
523
1.27
0.86
5.4
3.9
estimate
0.0
0.0
0.00
25
162
(3022217) INR in Platelet poor plasma by Coagulation assay
41
321
1.33
0.86
23.9
23.7
inr
1.5
1.4
—
7
52
(3021879) Hepatitis B virus core Ab [Presence] in Serum
15
97
1.58
0.83
1.5
1.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
81
696
1.24
0.82
3.6
3.7
e6/l
78.6
101.7
0.24
63
486
(3020564) Creatinine [Moles/volume] in Serum or Plasma
226
2160
1.31
0.82
24.3
14.8
umol/l
78.6
79.8
0.33
226
2160
(40761511) CBC panel - Blood by Automated count
222
2117
1.30
0.82
19.3
11.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
9
149
0.59
0.81
1.8
1.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
0
24
0.00
0.79
0.0
1.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
62
519
1.25
0.79
2.8
2.9
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
64
541
1.24
0.75
3.3
3.0
e6/l
0.3
0.4
0.61
54
390
(3002582) Erythrocytes [#/volume] in Urine
70
598
1.23
0.75
3.3
3.1
e6/l
31.6
161.7
0.62
57
451
(3022806) Fractional oxyhemoglobin in Capillary blood
5
24
2.10
0.75
2.2
1.5
%
93.6
90.0
—
5
24
(3017732) Neutrophils [#/volume] in Blood
20
142
1.44
0.75
2.2
2.5
e9/l
3.3
3.8
0.56
12
101
(3017143) Hepatitis C virus Ab [Presence] in Serum
23
168
1.40
0.74
1.4
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
52
621
0.80
0.73
3.5
3.6
%
18.9
24.2
2.07
29
283
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
6
110
0.54
0.73
1.3
1.5
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
5
25
2.02
0.73
1.2
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
31
240
1.33
0.71
1.4
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
25
188
1.36
0.69
1.5
1.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
5
27
1.87
0.69
2.2
1.6
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
86
1.54
0.67
1.2
1.3
g/l
3.6
3.9
—
7
58
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
86
1.54
0.67
1.2
1.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
86
1.54
0.67
1.2
1.3
g/l
6.9
7.5
—
8
62
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
226
2175
1.27
0.65
12.5
9.0
u/l
24.3
25.2
0.56
210
2072
(3007461) Platelets [#/volume] in Blood
233
2253
1.28
0.62
29.3
18.4
e9/l
241.9
246.2
0.42
224
2183
(3024731) MCV [Entitic volume]
233
2254
1.28
0.61
29.2
18.3
fl
90.9
91.2
0.45
226
2206
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
233
2255
1.28
0.60
29.3
18.4
e12/l
4.4
4.5
4.35
222
2175
(3035941) MCH [Entitic mass]
233
2255
1.28
0.60
29.1
18.3
pg
30.1
30.4
1.33
226
2207
(3010813) Leukocytes [#/volume] in Blood
233
2255
1.28
0.60
29.3
18.4
e9/l
6.6
6.7
0.05
224
2177
(3000963) Hemoglobin [Mass/volume] in Blood
233
2255
1.28
0.60
29.4
18.5
g/l
131.2
136.9
6.38
226
2207
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
21
0.00
0.60
0.0
1.0
—
280.5
—
0
15
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
21
0.00
0.60
0.0
1.0
—
39.9
—
0
14
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
21
0.00
0.60
0.0
1.0
—
600.7
—
0
15
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
0
22
0.00
0.59
0.0
2.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
12
81
1.50
0.58
1.2
1.3
g/l
2.6
3.1
—
7
59
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
21
159
1.35
0.57
3.3
4.0
ng/l
94.3
84.5
0.31
15
138
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
97
878
1.17
0.55
4.4
3.8
ng/l
60.2
43.9
0.33
77
639
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
139
1293
1.16
0.55
3.1
3.0
u/l
61.2
46.0
0.84
128
1198
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
195
2032
0.85
0.54
4.2
4.8
mmol/l
1.4
1.5
0.50
169
1851
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
9
62
1.47
0.53
1.4
1.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
195
2030
0.85
0.52
4.3
4.9
mmol/l
6.0
6.1
0.10
170
1826
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
197
2049
0.85
0.51
4.0
4.8
mmol/l
4.7
4.6
0.37
169
1871
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
200
1918
1.17
0.50
21.2
11.5
ml/min/173m2
77.8
77.0
0.21
166
1530
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
10
67
1.51
0.50
2.3
2.2
ug/l
229.1
353.0
—
10
59
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
7
48
1.47
0.47
1.1
1.7
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
8
116
0.68
0.47
2.6
2.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
37
434
0.83
0.45
2.2
2.6
ug/l
0.7
0.8
0.33
25
277
(40768443) Skin Pathology biopsy report
10
69
1.47
0.45
1.1
1.3
—
—
—
0
0
(3000492) Spirometry study
14
185
0.74
0.44
1.2
1.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
15
0.00
0.41
0.0
1.7
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
17
0.00
0.41
0.0
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
17
0.00
0.41
0.0
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
17
0.00
0.41
0.0
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
17
0.00
0.41
0.0
1.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
203
2095
0.87
0.40
4.5
5.4
mmol/l
2.8
2.7
0.32
175
1910
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
18
0.00
0.40
0.0
1.1
—
1.1
—
0
12
(4027681)
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.7
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
190
1966
0.88
0.38
3.7
4.3
mmol/l
1.3
1.3
0.07
164
1777
(4010399)
20
162
1.25
0.37
1.5
1.4
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
23
192
1.22
0.33
2.6
3.4
mmol/l
2.2
2.3
0.02
16
149
(3009508) Creatinine [Moles/volume] in Urine
67
730
0.89
0.32
3.1
3.1
mmol/l
7.7
7.5
0.08
53
603
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
18
218
0.81
0.31
1.4
1.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
7
52
1.36
0.31
1.0
1.1
—
—
—
0
0
(4034850)
10
75
1.35
0.30
19.4
9.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
10
130
0.76
0.30
1.5
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
7
55
1.28
0.30
1.9
1.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
19
158
1.22
0.29
7.5
3.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
65
703
0.90
0.28
3.0
3.3
mg/l
1125.6
236.6
0.38
40
439
(3049717) Cytology report of Urine Cyto stain
8
64
1.26
0.27
1.7
1.7
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
47
426
1.13
0.27
4.0
4.0
ng/l
23.4
257.1
1.84
37
344
(3012544) pH of Venous blood
23
197
1.18
0.27
2.5
3.4
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
5
73
0.68
0.26
1.0
1.0
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
28
245
1.16
0.26
2.5
2.4
%
18.8
24.5
1.29
23
210
(3009445) Proteinase 3 Ab [Units/volume] in Serum
6
85
0.70
0.24
1.0
1.3
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
5
38
1.32
0.23
1.0
1.2
iu/l
28.1
28.7
—
5
33
(46235355) HIV 1 and 2 tests - Meaningful Use set
27
238
1.15
0.23
1.5
1.6
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
192
1873
1.09
0.23
4.7
4.6
mu/l
2.1
2.6
0.31
165
1676
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
5
39
1.29
0.23
1.8
1.6
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
14
116
1.22
0.22
1.1
1.2
u/ml
140.9
222.0
0.68
14
108
(3021960) Folate [Moles/volume] in Serum or Plasma
47
510
0.90
0.22
1.9
1.5
nmol/l
20.3
21.6
0.18
37
435
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
11
0.00
0.21
0.0
3.1
—
13.7
—
0
11
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
0
11
0.00
0.21
0.0
9.8
—
37.8
—
0
5
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
70
744
0.92
0.21
4.3
4.0
mg/mmol
5.3
6.6
0.30
43
461
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
5
43
1.17
0.21
1.0
1.3
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
6
48
1.26
0.20
1.7
2.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
12
144
0.83
0.20
2.0
2.7
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
14
0.00
0.20
0.0
1.7
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
14
0.00
0.20
0.0
1.7
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
59
1.19
0.18
1.6
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
11
131
0.83
0.17
2.0
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
5
66
0.75
0.17
1.8
1.8
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
5
70
0.71
0.17
1.6
2.0
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
37
342
1.10
0.16
3.3
2.6
e6/l
1.6
1.0
0.52
28
193
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
194
1970
0.94
0.13
5.8
6.4
mmol/mol
39.9
40.4
0.40
167
1820
(3001122) Ferritin [Mass/volume] in Serum or Plasma
78
811
0.95
0.13
2.7
2.6
ug/l
135.1
123.5
0.17
65
738
(3013512) EKG study
62
649
0.94
0.13
4.6
4.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
101
979
1.05
0.12
4.7
3.7
estimate
0.0
0.0
0.00
24
163
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
86
889
0.95
0.11
2.4
1.9
pmol/l
95.9
95.8
0.00
39
444
(3018677) aPTT in Platelet poor plasma by Coagulation assay
29
311
0.92
0.11
1.7
1.7
s
29.3
29.5
0.05
29
302
(3037467) Urinalysis macro (dipstick) panel - Urine
141
1381
1.04
0.11
5.1
4.2
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
13
115
1.14
0.10
4.7
2.7
e6/l
0.1
0.1
0.06
13
110
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
26
278
0.93
0.09
1.5
1.4
—
—
—
0
0
(3015736) pH of Urine
80
776
1.04
0.09
4.2
3.5
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
6
57
1.05
0.08
1.5
1.2
u/ml
2.2
3.6
—
6
12
(3000330) Specific gravity of Urine by Test strip
10
113
0.88
0.08
4.6
3.6
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
48
500
0.95
0.08
2.2
2.1
mg/l
3.5
3.0
0.27
33
414
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
26
244
1.07
0.08
1.6
1.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
57
550
1.05
0.08
2.6
2.4
umol/l
339.4
6158.3
2.28
47
477
(3037522) Nuclear Ab [Titer] in Serum
24
256
0.93
0.08
1.2
1.3
titre
415.0
563.1
—
8
64
(1002224) Polysomnography panel
7
81
0.86
0.07
1.0
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
79
770
1.04
0.07
5.0
3.8
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
7
85
0.82
0.07
1.0
1.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
8
91
0.88
0.07
1.5
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
46
445
1.04
0.05
1.5
1.7
pmol/l
459.9
438.7
0.16
36
358
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
29
279
1.04
0.04
5.1
4.9
%
33.7
32.6
0.14
17
181
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
108
1093
0.98
0.03
2.7
2.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
98
992
0.98
0.03
5.6
5.0
estimate
0.0
0.0
0.00
25
163
(3009261) Glucose [Presence] in Urine by Test strip
99
1002
0.98
0.03
4.8
3.7
estimate
0.0
0.0
0.00
25
158
(3009542) Hematocrit [Volume Fraction] of Blood
182
1811
1.02
0.02
19.3
13.5
%
38.9
40.2
1.00
110
1236
(3011397) Hemoglobin [Presence] in Urine by Test strip
48
472
1.02
0.01
3.6
3.6
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
40
407
0.98
0.01
2.0
1.7
nmol/l
1266.9
1251.7
0.03
26
294
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
42
427
0.98
0.01
2.0
1.8
mg/l
1.8
1.0
0.85
32
326
(3041096) Erythrocytes [Presence] in Urine by Automated
54
533
1.02
0.01
5.0
3.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
10
98
1.02
0.00
4.7
3.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
35
348
1.01
0.00
2.0
1.2
g/l
1.9
2.6
2.38
27
192
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
32
321
1.00
0.00
3.8
2.9
e6/l
0.5
2.4
3.01
23
173
(40768797) Stomach Pathology biopsy report
29
293
0.99
0.00
1.4
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
10
103
0.97
0.00
1.1
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
19
193
0.98
0.00
1.2
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
17
174
0.98
0.00
3.8
2.9
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
6
61
0.98
0.00
3.3
3.7
—
—
—
0
0
(4094501)
6
61
0.98
0.00
1.2
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
8
86
0.93
0.00
7.5
7.5
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
5
0.00
0.00
0.0
5.8
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
6
0.00
0.00
0.0
6.2
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
6
67
0.89
0.00
1.5
1.2
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.4
—
154.6
—
0
5
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
0
5
0.00
0.00
0.0
1.4
—
194.2
—
0
5
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
91.1
—
0
8
(3014765) Yersinia sp identified in Stool by Organism specific culture
6
66
0.91
0.00
1.5
1.2
—
—
—
0
0
(4198724)
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
9.3
—
0
9
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
5
0.00
0.00
0.0
4.2
—
89.2
—
0
5
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
11.2
—
1016.3
—
0
9
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
5
0.00
0.00
0.0
7.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
5
0.00
0.00
0.0
2.2
—
7.2
—
0
5
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
6
66
0.91
0.00
1.5
1.2
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
3.1
—
0
5
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
10.3
—
0.7
—
0
8
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
6
0.00
0.00
0.0
6.3
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
1.8
—
0
6
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
0
8
0.00
0.00
0.0
5.5
—
24.9
—
0
8
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_SALIVARYNAS_EXALLC – Malignant neoplasm of other and unspecified major salivary glands, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).